effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_consumer.pdf
September 01, 2016 - Comparing Talk Therapy and Other Depression Treatments With Antidepressant Medicines
Comparing Talk Therapy and
Other Depression Treatments
With Antidepressant Medicines
A Review of the Research for Adults
e
Is This Information Right for Me?
This information is right for you if:
�Your health care professional…
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-238-cervical-ripening-evidence-summary.pdf
March 01, 2021 - Evidence Summary: Comparative Effectiveness Review No. 238: Cervical Ripening
Comparative Effectiveness Review
Number 238
Cervical Ripening in the Outpatient
Setting
Evidence Summary
Main Points
• The highest strength of evidence for outcomes of outpatient cervical ripening
found in this report was low, with …
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-272-genitourinary-syndrome-disposition-comments.pdf
July 31, 2024 - Disposition of Comments_Comparative Effectiveness Review No. 272_Genitourinary Syndrome of Menopause: A Systematic Review
Comparative Effectiveness Review Disposition of Comments Report
Title: Genitourinary Syndrome of Menopause: A Systematic Review
Draft report available for public comment from Dec…
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/head-neck-cancer_executive.pdf
May 01, 2010 - Layout 1
Background
Head and neck cancers, specifically those
arising in the oral cavity, larynx,
hypopharynx, oropharynx, nasopharynx,
paranasal sinuses/nasal cavity, salivary
glands, and occult primaries, account for
approximately 3 to 5 percent of cancers in
the United States. According to the
National Comprehens…
effectivehealthcare-admin.ahrq.gov/products/plant-based-chronic-pain-treatment/draft-report
April 01, 2025 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-screening_executive.pdf
April 01, 2012 - The
investigators acknowledge that use of topical medications
by the glaucoma participants could limit
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
June 07, 2013 - As
with most medications, there are risks that come with the
use of oral contraceptives.
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
March 01, 2016 - We contacted manufacturers of the
prescription medications used to treat gout that are listed
in Table … Discontinuation of
Pharmaceutical Management for Patients
on Acute or Chronic Gout Medications
In … Steroids are one of the most powerful
and effective anti-inflammatory medications available. … Uricosuric medications for
chronic gout. Cochrane Database Syst Rev. 2014;11:CD010457. … Increased risk of skin reactions
with gout medications: An analysis of va databases.
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
December 01, 2011 - Layout 1
Background
Coronary stents and adjunctive
pharmacologic agents—including
glycoprotein IIb/IIIa receptor inhibitors and
thienopyridines—have improved the
efficacy of percutaneous coronary
intervention (PCI).1,2 However,
dislodgement of atherothrombotic material
from coronary lesions during PCI can
result in …
effectivehealthcare-admin.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-report-improving-health-systems-access.pdf
August 01, 2019 - Methods Research Report: Improving Health Systems' Access to High-Quality Evidence: AHRQ EPC 2018 Pilot Projects Summary
Methods Research Report
Improving Health Systems’ Access to High-Quality
Evidence: AHRQ EPC 2018 Pilot Projects Summary
Methods Research Report
Improving Health Syst…
effectivehealthcare-admin.ahrq.gov/sites/default/files/coronary-artery-disease-testing_disposition-comments.pdf
March 29, 2016 - Disposition of Comments for CER 171 Noninvasive Testing for Coronary Artery Disease
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Noninvasive Testing for Coronary Artery Disease
Draft review available for public comment from August 5, 2015 to September 2, 2015.
Research …
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/sleep-apnea_surveillance.pdf
April 01, 2012 - AHRQ Comparative Effectiveness Review
Surveillance Program
CER #32:
Diagnosis and Treatment of Obstructive Sleep Apnea
in Adults
Original release date:
August 8, 2011
Surveillance Report:
July, 2012
Key Findings:
- The conclusions for KQ2 (phased testing), KQ3
(preoperative screening), KQ6 (compliance…
effectivehealthcare-admin.ahrq.gov/health-topics/vascular-diseases?page=0
June 21, 2018 - Cardiovascular Disease - Update
Research Protocol Archived January 22, 2015
Diabetes Medications
effectivehealthcare-admin.ahrq.gov/health-topics/health-facilities?page=4
July 12, 2011 - in Adult Women
Research Report Archived July 30, 2010
Prompt Reduction in Use of Medications
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
August 01, 2016 - * Specifically, CV medications, statins, antihypertensives, diabetes medications, hormone replacement